People: BioScrip Inc (BIOS.O)

BIOS.O on Nasdaq

7.20USD
15 Apr 2014
Price Change (% chg)

$-0.02 (-0.28%)
Prev Close
$7.22
Open
$7.22
Day's High
$7.37
Day's Low
$7.02
Volume
1,418,939
Avg. Vol
1,801,268
52-wk High
$17.62
52-wk Low
$5.61

Search Stocks

Summary

Name Age Since Current Position

Myron Holubiak

66 2012 Independent Chairman of the Board

Richard Smith

53 2013 President, Chief Executive Officer, Director

Hai Tran

43 2012 Chief Financial Officer, Treasurer

Richard Jenkins

48 2013 Interim Chief Operating Officer

Brian Stiver

50 2012 Senior Vice President - National Infusion Sales

Vito Ponzio

58 2010 Senior Vice President - Human Resources

David Evans

48 2009 Senior Vice President - Strategic Operations

Barbara Cormier

69 2012 Chief Compliance Officer and Privacy Officer

Patricia Bogusz

53 2011 Vice President - Finance, Principal Accounting Officer

Daniel Colucci

47 2011 Vice President - PBM Services

Charlotte Collins

60 2003 Independent Director

Samuel Frieder

49 2010 Independent Director

David Hubers

70 2005 Independent Director

Huong Thi Nguyen

41 2014 Independent Director

Richard Robbins

72 2005 Independent Director

Stuart Samuels

71 2005 Independent Director

Gordon Woodward

44 2010 Independent Director

Lisa Carlton-Wilson

President

Biographies

Name Description

Myron Holubiak

Mr. Myron Z. Holubiak is Independent Chairman of the Board of BioScrip Inc. Prior to being appointed a director of the Company he had served as a director of Chronimed since September 2002. Mr. Holubiak is the former President of Roche Laboratories, Inc. He held this position from December 1998 to August 2001. Currently, Mr. Holubiak is the President and a member of the board of directors of 1-800-Doctors, Inc., a medical referral company that provides consumers access to physicians and hospitals. Mr. Holubiak has been serving as a member of the board of directors of IntelliCell Biosciences, Inc. since October 2012 and as a member the board of Ventrus Biosciences, Inc. since July 2010.

Richard Smith

Mr. Richard M. Smith is President, Chief Executive Officer, Director of BioScrip Inc. Mr. Smith joined the Company as its President and Chief Operating Officer in January 2009 and was appointed a director of the Company in September 2009. On January 1, 2011, Mr. Smith succeeded Richard H. Friedman as the Company’s Chief Executive Officer. Prior to joining the Company, from June 2006 to December 2008 Mr. Smith was Chief Executive Officer and a director of Byram Healthcare Centers, Inc., a provider of medical supplies and pharmacy items to long-term chronic patients. From May 2003 to May 2006 Mr. Smith was the President and Chief Operating Officer of Option Care, Inc., a home infusion and specialty pharmaceutical company.

Hai Tran

Mr. Hai V. Tran serves as Chief Financial Officer, Treasurer of BioScrip Inc. Prior to joining the Company, Mr. Tran was the Chief Financial Officer and VP International of Harris Healthcare Solutions, a subsidiary of Harris Corporation, a diversified technology company. From 2008 to 2011, Mr. Tran served as Chief Financial Officer of Catalyst Health Solutions, Inc. (Nasdaq: CHSI), a publicly traded Pharmacy Benefits Management company. Mr. Tran served as Vice President and Treasurer of Hanger Orthopedic Group (NYSE: HGR), a public healthcare services, products, and distribution company, from 2006 to May 2008, and as Senior Vice President of Strategic Development and Emerging Solutions for Cadmus Communications from 2001 to 2006. Prior to working at Cadmus Communications, Mr. Tran served in various financial and strategic positions at private and public companies. Mr. Tran holds a bachelor’s degree in electrical engineering from the University of Virginia and a master’s degree in business administration from the University of Richmond.

Richard Jenkins

Mr. Richard C. Jenkins has been appointed as Interim Chief Operating Officer of the Company.Mr. Jenkins was appointed by the Company in accordance with an engagement letter dated November 27, 2013 (the “Engagement Letter”) that the Company entered into with Alvarez & Marsal Private Equity Performance Improvement Group, LLC (“Alvarez & Marsal”). Mr. Jenkins joined Alvarez & Marsal in 2001 and serves as a Managing Director based in Denver. While at Alvarez & Marsal, Mr. Jenkins has worked as a C-level executive for a number of companies where he has focused on improving operational and financial performance and developing comprehensive long-term strategic plans. Mr. Jenkins’ experience with Alvarez & Marsal has included his service in the following positions: Interim Chief Executive Officer for AGY Holding Corp. from December 2011 through July 2013, Interim Chief Financial Officer for Local Insight Media Holdings, Inc. from October 2009 through October 2011, and Interim Chief Financial Officer for Electro-Motive Diesel, Inc. from November 2008 through July 2009. Mr. Jenkins holds a bachelor’s degree in finance from Colorado State University.

Brian Stiver

Mr. Brian Stiver serves as Senior Vice President - National Infusion Sales of BioScrip Inc. Prior to joining BioScrip, Mr. Stiver was Vice President, Specialty Pharmacy, at Walgreen Co.

Vito Ponzio

Mr. Vito Ponzio, Jr., serves as Senior Vice President - Human Resources of BioScrip Inc. Mr. Ponzio was appointed Senior Vice President of Human Resources on December 2010. Mr. Ponzio joined BioScrip in January 2010 and was responsible for all operations aspects of the Community Store Division. Previously, Mr. Ponzio was the Senior Vice President, Administration for Coram Specialty Infusion Services (“Coram”), a division of Apria Healthcare. He was with Coram for 19 years, from 1990 to 2009, and was responsible for human resources, legal, risk management, facilities and construction management, clinical operations and payroll. During his tenure, he also held the position of Compliance Officer and EEO Officer of Coram and served on the Board of Directors for all Coram subsidiary companies.

David Evans

Mr. David Evans serves as Senior Vice President - Strategic Operations of BioScrip Inc. Mr. Evans has been in the health care provider arena for 24 years. Mr. Evans joined BioScrip in February 2009. Prior to joining BioScrip, from August 2006 to July 2008, Mr. Evans was Chief Financial Officer and Secretary of Byram Healthcare Centers, Inc., a provider of medical supplies and pharmacy items to long term chronic patients, departing after the sale of the Company to Mediq, formerly named OPG Groep NV. From June 2003 to August 2006, Mr. Evans was the Corporate Vice President, Strategic Operations of Option Care, Inc., a home infusion and specialty pharmaceutical company.

Barbara Cormier

Ms. Barbara Cormier serves as Chief Compliance Officer and Privacy Officer of BioScrip Inc. Ms. Cormier joined BioScrip in March 2000 as the Vice President of Pharmaceutical Relations, she was appointed Chief Compliance Officer in 2003.

Patricia Bogusz

Ms. Patricia Bogusz serves as Vice President - Finance, Principal Accounting Officer of BioScrip Inc. Ms. Bogusz was Vice President and Controller from July, 2007 to April, 2011. Prior to joining BioScrip, Ms. Bogusz served in various divisional controller, customer quality assurance and internal audit positions at Carlson Companies, The Valspar Corporation, and Burlington Northern Santé Fe Corporation.

Daniel Colucci

Mr. Daniel Colucci serves as Vice President - PBM Services of BioScrip Inc. He joined BioScrip in 2001 and has served as Vice President of PBM Services for BioScrip since April of 2005. Dan manages BioScrip’s PBM Services division. Dan previously served as Vice President, Provider Affairs for Scrip Solutions, LLC (a BioScrip predecessor company), effective July 2002. Prior to that he was Director of Sales and Marketing Operations for Scrip Solutions. Previous to BioScrip, Dan worked for PharmaCare Management Services as Sales Director and Manager of Market Development and for ValueRx as Director of Client Research and Director of Marketing Research.

Charlotte Collins

Ms. Charlotte W. Collins, Esq., is Independent Director of BioScrip Inc since April 2003. Since January 2008, she has been a senior executive for the Asthma and Allergy Foundation of America. From 2003 to 2007, she was Associate Professor of Health Services Management and Leadership, and Health Policy at the George Washington University School of Public Health and Health Services. From January 2002 to June 2003, she was an Associate Research Professor of Health Policy at the same university. She served a four year term on the National Allergy and Infectious Diseases Advisory Council of the National Institutes of Health beginning in 2001. From September 1996 to November 2004, Ms. Collins was Of Counsel in the health policy practice of the law firm of Powell, Goldstein LLP in its Washington DC office. She served as General Counsel of the Regional Medical Center at Memphis for ten years until 1996 and served as interim General Counsel for the District of Columbia Health and Hospitals Public Benefit Corporation in 1998. In 1993, Ms. Collins co-founded a managed care plan and served on its board of directors through 1996. She has also served on the boards of two primary care centers, a Medicare Part A intermediary company, and as a leadership coach for the Robert Wood Johnson Foundation’s Health Policy Fellows program. In 2006, Modern Healthcare magazine named her one of the top 25 most influential minority healthcare executives.

Samuel Frieder

Mr. Samuel P. Frieder is Independent Director of BioScrip Inc. He the Managing Partner of Kohlberg & Co., L.L.C. (“Kohlberg”) and a member of Kohlberg’s Investment Committee. Mr. Frieder joined Kohlberg in 1989, became a principal in 1995 and named Managing Partner in 2006. He is a member of the board of directors of AGY Holdings Corporation, Aurora Casket Company, Bauer Performance Sports, Chronos Life Group, Concrete Technologies Worldwide, e+CancerCare, Katy Industries, Kellermeyer Bergensons Services, Nielsen & Bainbridge, Packaging Dynamics Corporation, Pittsburgh Glass Works, Phillips-Medisize Corporation, Sabre Industries, Inc., SouthernCare, Stanadyne Corporation, SVP Holdings and Trico Products. Mr. Frieder received an A.B. from Harvard College.

David Hubers

Mr. David R. Hubers is an Independent Director of BioScrip Inc. since March 2005. Prior to being appointed a director of the Company he had served as a director of Chronimed since November 2000. Mr. Hubers was Chairman of American Express Financial Advisors, Inc. prior to his retirement. He joined American Express Financial Advisors Inc. in 1965 and held various positions, including Senior Vice President of Finance and Chief Financial Officer until being appointed President and Chief Executive Officer in August 1993. He served in that capacity until June 2001. Mr. Hubers served on the boards of directors of the Carlson School of Management at the University of Minnesota and Lawson Software.

Huong Thi Nguyen

Dr. Huong Thi Nguyen, M.D., is Independent Director of the Company. Dr. Nguyen is an industry veteran with more than 20 years of leadership experience in managed care and health insurance. She currently serves as the president of Texas Health Population Health, Education, Research and Innovation Center, an organization devoted to sharing best practices, disseminating information about innovative approaches, leading physician-directed population health initiatives and coordinating community-based well-being collaboration. Until September 2013, Dr. Nguyen served as the Chief Medical Officer of Banner Health Network, where she oversaw the activities of more than 2,500 physicians. Between 2008 and 2011 she held senior positions at Blue Cross Blue Shield in Kansas City and Florida. From August 2005 to April 2008, Dr. Nguyen was Vice President and Market Medical Officer of Humana, Inc., a managed health care company that markets and administers health insurance. Dr. Nguyen received her medical degree from the University of Missouri’s Columbia School of Medicine and her Bachelors of Science from Creighton University School of Pharmacy. She also holds a Medical Management Executive MBA from the University of Texas at Dallas.

Richard Robbins

Mr. Richard L. Robbins is an Independent Director of BioScrip Inc. since March 2005. From October 2003 through March 2006, Mr. Robbins was Senior Vice President, Financial Reporting and Control and Principal Financial Officer of Footstar, Inc., a nationwide retailer of footwear. From July 2002 to October 2003, Mr. Robbins was a partner of Robbins Consulting LLP, a financial, strategic and management consulting firm. From 1978 to 2002, Mr. Robbins was a partner of Arthur Andersen LLP. From December 2002 to March 2003, Mr. Robbins served on the board of directors of Bionx Corp., a medical products company. From May 2003 to October 2008, Mr. Robbins served on the board of directors of Vital Signs, Inc., a medical products company. From August 2007 to February 2008, Mr. Robbins served on the board of directors of American Banknote Holographics, Inc. From August 2007 to April 2009, Mr. Robbins served on the board of directors of Empire Resorts, Inc. Since January 2012, Mr. Robbins has served on the audit committee of Resorts Casino Hotel.

Stuart Samuels

Dr. Stuart A. Samuels is an Independent Director of BioScrip Inc. since March 2005. Prior to being appointed a director of the Company he had served as a director of Chronimed since November 2000. Since 1990, Dr. Samuels has been a management consultant, specializing in business management, strategic sales and marketing and business development for several companies, specifically in the pharmaceutical and healthcare industries. Dr. Samuels served on the board of directors of Target Rx, Inc. from 2000-2011, and the board of Infomedics, Inc. from 2005-2012. He currently serves as a Business Monitor for the Federal Trade Commission.

Gordon Woodward

Mr. Gordon H. Woodward is an Independent Director of BioScrip Inc. Mr. Woodward is a Partner and Chief Investment Officer of Kohlberg & Co, L.L.C. (“Kohlberg”) and a member of Kohlberg’s Investment Committee. Mr. Woodward joined Kohlberg in 1996, became a Partner in 2001 and Chief Investment Officer in 2010. He is a member of the board of directors of Aurora Casket Company, Bauer Performance Sports, Chronos Life Group, e+CancerCare, Kellermeyer Bergensons Services, Nielsen & Bainbridge, Packaging Dynamics Corporation, Pittsburgh Glass Works, Phillips-Medisize Corporation, Sabre Industries, SouthernCare, Stanadyne Corporation and Standard Parking Corporation. Prior to joining Kohlberg, Mr. Woodward was with James D. Wolfensohn Incorporated. Mr. Woodward received an A.B. from Harvard College.

Lisa Carlton-Wilson

Search Stocks